Home › Funds › GRIZZLYROCK CAPITAL, LLC › LFCR
GRIZZLYROCK CAPITAL, LLC position in LFCR
LIFECORE BIOMEDICAL INC · Health Care
GRIZZLYROCK CAPITAL, LLC reported holding 103,000 shares of LFCR (LIFECORE BIOMEDICAL INC) in its Q2 2026 13F filing — a position valued at US$541K, representing 0.38% of its reported portfolio and ranking #20 among its reported holdings. GRIZZLYROCK CAPITAL, LLC has disclosed LFCR holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How GRIZZLYROCK CAPITAL, LLC's LFCR position evolved
GRIZZLYROCK CAPITAL, LLC first disclosed a stake in LFCR in Q2 2025 at 734,533 shares (US$6.0M). The position peaked in Q4 2025 at 743,241 shares, worth US$6.1M. Across 5 filings, GRIZZLYROCK CAPITAL, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 103,000 shares valued at US$541K — a reduction of -724,488 shares quarter over quarter.. Notable position changes include a 88% trim in Q2 2026 (shares rose 25% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 734.53K | $5.96M | New |
| Q3 2025 | 738.88K | $5.44M | Add |
| Q4 2025 | 743.24K | $6.08M | Add |
| Q1 2026 | 827.49K | $3.08M | Add |
| Q2 2026 | 103.00K | $540.75K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LFCR and 13F data
LFCR (LIFECORE BIOMEDICAL INC) is a Health Care company. 22 other funds we track also report a position in LFCR — the largest reported positions include WYNNEFIELD CAPITAL INC (US$24.7M), Legion Partners Asset Management, LLC (US$23.4M), Greenhaven Road Investment Management, L.P. (US$16.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LFCR
- WYNNEFIELD CAPITAL INC 4.70M sh · $24.69M · Q2 2026
- Legion Partners Asset Management, LLC 4.46M sh · $23.42M · Q2 2026
- Greenhaven Road Investment Management, L.P. 3.19M sh · $16.75M · Q2 2026
- 325 CAPITAL LLC 2.90M sh · $15.20M · Q2 2026
- DCF Advisers, LLC 424.50K sh · $2.23M · Q2 2026
- WITTENBERG INVESTMENT MANAGEMENT, INC. 314.01K sh · $1.65M · Q2 2026
More on GRIZZLYROCK CAPITAL, LLC
FAQ
How long has GRIZZLYROCK CAPITAL, LLC held LFCR?
GRIZZLYROCK CAPITAL, LLC has disclosed LFCR holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is GRIZZLYROCK CAPITAL, LLC's current position in LFCR?
As of Q2 2026, GRIZZLYROCK CAPITAL, LLC holds 103.00K shares of LFCR (LIFECORE BIOMEDICAL INC), valued at $540.75K, representing 0.38% of its reported portfolio and ranking #20.
Has GRIZZLYROCK CAPITAL, LLC been buying or selling LFCR?
In the latest 13F filing (Q2 2026), GRIZZLYROCK CAPITAL, LLC reduced its position in LFCR. The position peaked in Q4 2025 at 743.24K shares.
Which other funds hold LFCR?
Other major institutional holders of LFCR include WYNNEFIELD CAPITAL INC, Legion Partners Asset Management, LLC, Greenhaven Road Investment Management, L.P., among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.